Needle-free Injection System - Stratis(R) - was used to deliver Scancell's iSCIB1+ DNA immunotherapy in combination with immune checkpoint inhibitors in the SCOPE Phase 2 trial. -- The Scancell ...

Expected Revenue Growth. What This Report Will Provide? Target Audience. Based on the technology, the market is divided into Jet-based needle-free injectors, spring-based needle-free injectors, ...

GOLDEN, Colo.--(BUSINESS WIRE)--PharmaJet ®, a company who has developed and commercialized an intradermal needle-free platform to more effectively administer drugs and biologics, today announced that ...

GOLDEN, Colo.--(BUSINESS WIRE)--PharmaJet ®, a company who has developed and commercialized a needle-free platform to more effectively administer drugs and biologics, today announced that they will ...

Growth in Needle-Free Injection System market. Market Dynamics. Some key players. The global needle-free injection system market, in terms of value, is projected to reach USD 20.17 Billion by 2021 ...

First self-administered, needle-free injection system approved by Health Canada gives access to safe, painless, cost-effective, and more sustainable drug delivery for chronic illnesses Toronto, ...

PharmaJet, a company that strives to improve the performance and outcomes of injectables with its innovative needle-free injection technology, today announced that their WHO prequalified Tropis ID ...

PharmaJet’s intramuscular (IM) Needle-free Injection System - Stratis ® - was used to deliver Scancell’s iSCIB1+ DNA immunotherapy in combination with immune checkpoint inhibitors in the SCOPE Phase 2 ...